» Articles » PMID: 35954420

Actin Retrograde Flow Regulated by the Wiskott-Aldrich Syndrome Protein Drives the Natural Killer Cell Response

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Aug 12
PMID 35954420
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the crosstalk between natural killer (NK) cells and the tumor microenvironment (TME) has enhanced the potential of exploiting the interplay between activation and inhibition of NK cells for immunotherapy. This interaction is crucial for understanding how tumor cells escape NK cell immune surveillance. NK cell dysfunction is regulated by two molecular mechanisms, downregulated activating receptor ligand expression on the tumor cells, and upregulated inhibitory signals delivered to NK cells. Recent studies demonstrated the role of mechanotransduction in modulating NK cell responses in the TME. The immunological synapse represents a functional interface between the NK cell and its target, regulated by Actin Retrograde Flow (ARF), which drives the adhesion molecules and receptors toward the central zone of the immunological synapse (IS). Here, we further characterize the role of ARF in controlling the immune response of NK cells, using CRISPR/cas9-mediated Wiskott-Aldrich Syndrome protein (WASp) gene silencing of NK cells. We demonstrate that WASp regulates ARF velocity, affecting the conformation and function of the key NK inhibitory regulator, SH2-domain containing protein tyrosine phosphatase-1 (SHP-1), and consequently, the NK cell response. Our results demonstrate the potential of modulating the biophysical and intracellular regulation of NK activation as a promising approach for improving immunotherapy.

Citing Articles

Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity.

Sabag B, Puthenveetil A, Levy M, Joseph N, Doniger T, Yaron O EMBO J. 2024; 43(13):2552-2581.

PMID: 38637625 PMC: 11217363. DOI: 10.1038/s44318-024-00094-5.


Actin cytoskeleton remodeling at the cancer cell side of the immunological synapse: good, bad, or both?.

Ockfen E, Filali L, Pereira Fernandes D, Hoffmann C, Thomas C Front Immunol. 2023; 14:1276602.

PMID: 37869010 PMC: 10585106. DOI: 10.3389/fimmu.2023.1276602.

References
1.
Boztug K, Germeshausen M, Diez I, Gulacsy V, Diestelhorst J, Ballmaier M . Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome. Clin Genet. 2008; 74(1):68-74. DOI: 10.1111/j.1399-0004.2008.01019.x. View

2.
Sanborn K, Mace E, Rak G, DiFeo A, Martignetti J, Pecci A . Phosphorylation of the myosin IIA tailpiece regulates single myosin IIA molecule association with lytic granules to promote NK-cell cytotoxicity. Blood. 2011; 118(22):5862-71. PMC: 3228501. DOI: 10.1182/blood-2011-03-344846. View

3.
Caraux A, Kim N, Bell S, Zompi S, Ranson T, Lesjean-Pottier S . Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood. 2005; 107(3):994-1002. DOI: 10.1182/blood-2005-06-2428. View

4.
Ben-Shmuel A, Joseph N, Sabag B, Barda-Saad M . Lymphocyte mechanotransduction: The regulatory role of cytoskeletal dynamics in signaling cascades and effector functions. J Leukoc Biol. 2019; 105(6):1261-1273. DOI: 10.1002/JLB.MR0718-267R. View

5.
Tassi I, Presti R, Kim S, Yokoyama W, Gilfillan S, Colonna M . Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol. 2005; 175(2):749-54. DOI: 10.4049/jimmunol.175.2.749. View